$0.5065
0.006501.30%
At close: -
$0.5101
0.003600.71%
After Hours: Mar 21, 6:44 PM EDT
Comments
Loading...
Lineage Cell Therapeutics Earnings Estimates, EPS & Revenue | AMEX:LCTX | Benzinga
Lineage Cell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 8
EPS Estimate
$-0.040
Quarterly Revenue Estimate
$1.36M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$9.50M
Analyze the earnings history of Lineage Cell Therapeutics using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | — | — | $1.44M | $1.36M | — | — | 05/08/2025 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.03 | -$0.02 | 33.33% | $2.10M | $1.62M | $2.90M | 79.01% | 03/10/2025 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.03 | -$0.02 | 33.33% | $1.25M | $886.57K | $3.78M | 326.25% | 11/14/2024 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.04 | -$0.03 | 25.00% | $3.23M | $970.00K | $1.41M | 45.15% | 08/08/2024 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.04 | -$0.04 | 0.00% | $2.39M | $1.36M | $1.44M | 6.18% | 05/09/2024 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.04 | -$0.03 | 25.00% | $1.90M | $1.31M | $2.10M | 60.31% | 03/07/2024 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.04 | 0.00% | $3.00M | $2.59M | $1.25M | -51.89% | 11/09/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.03 | 25.00% | $4.55M | $2.20M | $3.23M | 46.59% | 08/10/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.03 | 25.00% | $5.24M | $2.01M | $2.39M | 18.71% | 05/11/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.17 | -$0.04 | -$0.03 | 25.00% | $1.20M | $2.57M | $1.90M | -26.07% | 03/09/2023 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.05 | -$0.03 | -$0.04 | -33.33% | $2.27M | $3.90M | $3.00M | -23.13% | 11/10/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.04 | -$0.04 | 0.00% | $512.00K | $3.68M | $4.55M | 23.72% | 08/11/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.01 | -$0.03 | -$0.04 | -33.33% | $391.00K | $7.32M | $5.24M | -28.46% | 05/12/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | $0.01 | -$0.05 | -$0.17 | -240.00% | $355.00K | $840.00K | $1.20M | 42.86% | 03/10/2022 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.05 | -$0.05 | -$0.05 | 0.00% | $571.00K | — | $2.27M | — | 11/10/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.04 | -$0.04 | -$0.03 | 25.00% | $386.00K | $480.00K | $512.00K | 6.67% | 08/12/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.06 | -$0.04 | -$0.01 | 75.00% | $514.00K | $790.00K | $391.00K | -50.51% | 05/13/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.03 | -$0.05 | $0.01 | 120.00% | $1.24M | $920.00K | $355.00K | -61.41% | 03/11/2021 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.11 | -$0.04 | -$0.05 | -25.00% | $567.00K | $430.00K | $571.00K | 32.79% | 11/04/2020 | Get Alert |
| LCTX | Lineage Cell Therapeutics | -$0.20 | -$0.04 | -$0.04 | 0.00% | $779.00K | $560.00K | $386.00K | -31.07% | 08/06/2020 | Get Alert |
| LCTX | Lineage Cell Therapeutics | $0.30 | -$0.05 | -$0.06 | -20.00% | $928.00K | $710.00K | $514.00K | -27.61% | 05/07/2020 | Get Alert |
Lineage Cell Therapeutics (LCTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $-0.02 | $-0.03 | 33.3 % |
| Q3 | 2024-11-14 | $-0.02 | $-0.03 | 33.3 % |
| Q2 | 2024-08-08 | $-0.03 | $-0.04 | 25.0 % |
| Q1 | 2024-05-09 | $-0.04 | $-0.04 | 0.00 % |
Lineage Cell Therapeutics (LCTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-10 | $2.90M | $1.62M | 79.0 % |
| Q3 | 2024-11-14 | $3.78M | $886.57K | 326.3 % |
| Q2 | 2024-08-08 | $1.41M | $970.00K | 45.1 % |
| Q1 | 2024-05-09 | $1.44M | $1.36M | 6.18 % |
FAQ
When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?
Lineage Cell Therapeutics (LCTX) is scheduled to report earnings on May 8, 2025. The last reported earnings were for reported on March 10, 2025 for Q4.
What were the latest earnings per share (EPS) for Lineage Cell Therapeutics (AMEX:LCTX)?
The Actual EPS was $-0.02, which beat the estimate of $-0.03.
What were Lineage Cell Therapeutics’s (AMEX:LCTX) revenues?
The Actual Revenue was $2.9M, which beat the estimate of $1.6M.
Browse earnings estimates, EPS, and revenue on all stocks.